Association between deletions in the preS1/2 region of the hepatitis B virus genome and persistently abnormal ALT levels in patients with chronic hepatitis B treated with nucleos(t)ide analogs. [PDF]
Sato Y +11 more
europepmc +1 more source
Quantitative Change of Hepatitis B Surface Antigen Leading to Final Hepatitis B Surface Antigen Loss in Patients with Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in China. [PDF]
Zhou T +7 more
europepmc +1 more source
Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes. [PDF]
Shimizu R +17 more
europepmc +1 more source
The efficiency of low-dose hepatitis B immunoglobulin plus nucleos(t)ide analogs in preventing posttransplant hepatitis B virus recurrence [PDF]
Vatansever S +4 more
europepmc +1 more source
Complementation of Wild-Type and Drug-Resistant Hepatitis B Virus Genomes to Maintain Viral Replication and Rescue Virion Production under Nucleos(t)ide Analogs. [PDF]
Wu C +10 more
europepmc +1 more source
[Effect of interferon or nucleos(t)ide analogs on hepatitis B-related hepatocellular carcinoma]. [PDF]
Liu ZH, Sun J.
europepmc +1 more source
Serum hepatitis B core antibody levels predict HBeAg seroconversion in chronic hepatitis B patients with high viral load treated with nucleos(t)ide analogs. [PDF]
Cai S, Li Z, Yu T, Xia M, Peng J.
europepmc +1 more source
Discovery of the nucleoside analogue FMAU as a broad-spectrum anti-orthopoxvirus inhibitor in vitro and in vivo using a structure-guided hit expansion strategy. [PDF]
Zheng T +10 more
europepmc +1 more source
qHBsAg Trajectories with Peg-IFNα-2b Add-on Therapy in Nucleos(t)ide Analog-experienced HBeAg-positive Chronic Hepatitis B. [PDF]
Hu K +6 more
europepmc +1 more source
Efficacy and safety of Tenofovir disoproxil fumarate (TDF) or Entecavir (ETV) combined with interferon for the treatment of chronic hepatitis B: a systematic review and meta-analysis. [PDF]
Yang S +10 more
europepmc +1 more source

